A New Class of Antiviral Therapy Could Treat COVID-19

SAN FRANCISCO, Dec. 9, 2021. As the SARS-CoV-2 virus mutates, new variants emerge that can better evade immunity and spread more widely. This causes an ongoing race, in which scientists and pharmaceutical companies must continually test and adapt...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials